U.S. Physical Therapy Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Für U.S. Physical Therapy wird ein Gewinn- und Umsatzwachstum von 47.5% bzw. 7.3% pro Jahr prognostiziert, während der Gewinn je Aktie voraussichtlich um 52.4% pro Jahr steigen soll.
Wichtige Informationen
47.5%
Wachstumsrate der Gewinne
52.36%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 18.4% |
| Wachstumsrate der Einnahmen | 7.3% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 21 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaThese 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Summary USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, primarily through partnership models, are central to USPH's growth strategy. The company expanded into the IIP sector in 2017 and has made several acquisitions. The U.S. rehab market is projected to exceed $40 billion by 2025, driven by demographic trends like an aging population, rising obesity, and a focus on cost-effective healthcare. Physical therapy has demonstratedcost-effectiveness in patient care, significantly reducing hospitalization ratesand total treatment costs. USPH's current stock valuepresents a favorable entry point, especially with market misconceptions aboutGLP-1 adoption impacting the physical therapy industry. Read the full article on Seeking AlphaIs U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 981 | 56 | N/A | N/A | 1 |
| 12/31/2027 | 896 | 72 | 83 | 108 | 7 |
| 12/31/2026 | 839 | 57 | 68 | 92 | 7 |
| 3/31/2026 | 788 | 8 | 67 | 84 | N/A |
| 12/31/2025 | 773 | 22 | 61 | 75 | N/A |
| 9/30/2025 | 751 | 36 | 57 | 70 | N/A |
| 6/30/2025 | 722 | 35 | 61 | 72 | N/A |
| 3/31/2025 | 692 | 33 | 56 | 66 | N/A |
| 12/31/2024 | 664 | 28 | 66 | 75 | N/A |
| 9/30/2024 | 639 | 14 | 73 | 82 | N/A |
| 6/30/2024 | 621 | 16 | 68 | 77 | N/A |
| 3/31/2024 | 606 | 18 | 66 | 75 | N/A |
| 12/31/2023 | 599 | 18 | 73 | 82 | N/A |
| 9/30/2023 | 585 | 24 | 64 | 72 | N/A |
| 6/30/2023 | 575 | 26 | 62 | 70 | N/A |
| 3/31/2023 | 564 | 28 | 50 | 58 | N/A |
| 12/31/2022 | 548 | 29 | 50 | 59 | N/A |
| 9/30/2022 | 536 | 39 | 48 | 57 | N/A |
| 6/30/2022 | 522 | 38 | 59 | 68 | N/A |
| 3/31/2022 | 509 | 37 | 61 | 70 | N/A |
| 12/31/2021 | 490 | 31 | 68 | 76 | N/A |
| 9/30/2021 | 477 | 31 | 78 | 86 | N/A |
| 6/30/2021 | 461 | 30 | 81 | 87 | N/A |
| 3/31/2021 | 418 | 32 | 95 | 101 | N/A |
| 12/31/2020 | 418 | 32 | 92 | 100 | N/A |
| 9/30/2020 | 423 | 30 | 82 | 91 | N/A |
| 6/30/2020 | 431 | 31 | 72 | 82 | N/A |
| 3/31/2020 | 473 | 29 | 55 | 65 | N/A |
| 12/31/2019 | 477 | 31 | N/A | 62 | N/A |
| 9/30/2019 | 472 | 30 | N/A | 65 | N/A |
| 6/30/2019 | 468 | 23 | N/A | 71 | N/A |
| 3/31/2019 | 457 | 18 | N/A | 71 | N/A |
| 12/31/2018 | 449 | 17 | N/A | 73 | N/A |
| 9/30/2018 | 442 | 18 | N/A | 70 | N/A |
| 6/30/2018 | 432 | 22 | N/A | 65 | N/A |
| 3/31/2018 | 421 | 21 | N/A | 58 | N/A |
| 12/31/2017 | 410 | 22 | N/A | 57 | N/A |
| 9/30/2017 | 392 | 20 | N/A | 53 | N/A |
| 6/30/2017 | 377 | 20 | N/A | 42 | N/A |
| 3/31/2017 | 363 | 21 | N/A | 51 | N/A |
| 12/31/2016 | 353 | 21 | N/A | 51 | N/A |
| 9/30/2016 | 348 | 20 | N/A | 48 | N/A |
| 6/30/2016 | 344 | 21 | N/A | 49 | N/A |
| 3/31/2016 | 337 | 21 | N/A | 49 | N/A |
| 12/31/2015 | 327 | 21 | N/A | 38 | N/A |
| 9/30/2015 | 320 | 21 | N/A | 45 | N/A |
| 6/30/2015 | 313 | 20 | N/A | 43 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: USPHDas prognostizierte Gewinnwachstum (47.5% pro Jahr) liegt über der Sparquote (3.5%).
Ertrag vs. Markt: USPHDie Erträge des Unternehmens (47.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).
Hohe Wachstumserträge: USPHEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: USPHDie Einnahmen des Unternehmens (7.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).
Hohe Wachstumseinnahmen: USPHDie Einnahmen des Unternehmens (7.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von USPH in 3 Jahren voraussichtlich hoch sein wird
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 12:26 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
U.S. Physical Therapy, Inc. wird von 15 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |